- Filed
- Jun 5, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted restated | Q3 2026 · Mar 31, 2026 | 12.59M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2026 | 12.78M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 13.02M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 13.42M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $1.61M |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $1.57M |
| Dividends Paid | Q3 2026 · Mar 31, 2026 | $862K |
| Dividends Paid | Q3 2026 · Mar 31, 2025 | $912K |
| Capex | Q3 2026 · Mar 31, 2026 | $40K |
| Capex | Q3 2026 · Mar 31, 2025 | $6K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $519K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$808K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $24.58M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $24.55M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $46.05M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $44.17M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $45.21M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $46.1M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $47.29M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $49.01M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $1.82M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $1.87M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $2.87M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $2.86M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $38.05M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $39.12M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $48.92M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $48.06M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $48.76M |
| Eps Diluted restated | Q3 2026 · Mar 31, 2026 | $0.21 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2026 | $0.26 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.03 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic restated | Q3 2026 · Mar 31, 2026 | $0.21 |
| Eps Basic restated | Q3 2026 · Mar 31, 2026 | $0.26 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $1.41M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $4.01M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $1.45M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $4.35M |
| Net Income | Q3 2026 · Mar 31, 2026 | $2.68M |
| Net Income | Q3 2026 · Mar 31, 2026 | $3.34M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$846K |
| Net Income | Q3 2026 · Sep 30, 2025 | $1.51M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$382K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$153K |
| Net Income | Q3 2026 · Dec 31, 2024 | −$86K |
| Net Income | Q3 2026 · Sep 30, 2024 | $315K |
| Operating Income | Q3 2026 · Mar 31, 2026 | $88K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$515K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$893K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.99M |